rediff.com
India As It Happens
India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
rediff News App
Hi Guest
About 824 results for "hcv"
 |
Johnson & Johnson (JNJ), Gilead Sciences, Inc. (GILD), AbbVie ...Johnson & Johnson (NYSE:JNJ) s hepatitis C drug, simeprevir, recently received Priority Review status from the FDA. It was a surprising validation for Johnson & Johnson (NYSE:JNJ)'s mid-stage project. But there are stronger candidates from Gilead ... InsiderMonkey.com, 1 day ago |
142 images for hcv | ||||
The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun 'Warehousing' and Preparing Their HCV Patients/PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, unaided, one in five surveyed gastroenterologists, hepatologists, and infectious disease ... NewsBlaze, 23 hours ago
Recent Advances in the Treatment of Chronic HCV
Diabetes Care, 4 days ago
Sofosbuvir in Patients without HCV Treatment Options
New England Journal of Medicine, 1 week ago
|
Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients/PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, ... NewsBlaze, 23 hours ago
|
Gilead's Sofosbuvir under European ReviewGilead Sciences Inc. (GILD) recently announced that its Marketing Authorisation Application (MAA) for HCV candidate sofosbuvir (formerly GS-7977), submitted to the European Medicines Agency (:EMA) on Apr 17, 2013, has been validated and is under ... Yahoo! Finance, 1 day ago
|
Watch This HCV PlayerBrandy is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited. Simeprevir does have a trick up its sleeve. The drug could offer near perfect efficacy when used in combo ... Motley Fool, 1 day ago
|
Pharma Times
|
ENANTA PHARMA - Debut of a Star- 2nd in the Oral IFN Free HCV Drug Race! - new market research reportGilead entered the HCV race with the acquisition of Pharmasset in 2011 and ABBV through its alliance with Enanta (ENTA) in 2006. Gilead's Sofosbuvir (PhIII, PMI) in combination with RBV and GS-5885 (PhIII, NS5A inhibitor) is all set to enter the ... TransWorldNews, 6 days ago
AbbVie receives breakthrough therapy designation from FDA for HCV regimen
Individual.com, 6 days ago
AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration - PRESS RELEASE
National AIDS Treatment Advocacy Project, 1 week ago
US FDA grants breakthrough therapy designation to AbbiVie's investigational HCV regimen containing protease inhibitor ABT-450
PharmaBiz, 2 weeks ago
More from: EON, CNBC...and 42 other sources
|
Frost & Sullivan: Truck Cabin Styling Becomes Popular as OEMs in Western Europe Look to Personalise Driving Experience(M2) For the past three decades heavy commercial vehicle (HCV) manufacturers in Western Europe have consistently introduced superior driver comfort, convenience, safety, and entertainment features in trucks. As their truck cabin Individual.com, 3 days ago
Frost and Sullivan: Truck Cabin Styling Becomes Popular as OEMs in Western Europe Look to Personalise Driving Experience
SPi World News, 2 days ago
|
Cryoelectron tomography of HCV [Microbiology]Hepatitis C virus (HCV) is a major cause of chronic liver disease, with an estimated 170 million people infected worldwide. Low yields, poor stability, and inefficient binding to conventional EM grids have posed significant challenges to the ... PNAS, 3 days ago
New antiviral treatment could significantly reduce global burden of hepatitis C - New Study
National AIDS Treatment Advocacy Project, 1 week ago
Evaluating the Role of Macrocycles in the Susceptibility of Hepatitis C Virus NS3/4A Protease Inhibitors to Drug Resistance
Bionity.com, 2 weeks ago
Global Burden Of Hepatitis C Could Be Significantly Reduced By New Antiviral Treatment
Medical News Today, 2 weeks ago
More from: , MediLexicon...and 3 other sources
|
GILEAD SCIENCES - New HIV + HCV Products to Sustain the Growth Trajectory - new market research reportInitial sales of newly added HIV products - Complera/ Eviplera (L, truvada + rilpivirine), Stribild (L in US, R in EU, truvada+ cobicistat+ elvitegravir) along with growth in other marketed products contributed to the impressive 4Q12/FY13 results of ... TransWorldNews, 4 days ago
|
Gulf Times
|
Experts urge baby boomers to get screened for HCVIf you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening. Hepatitis C is a contagious disease affecting primarily the ... News-Medical.Net, 2 days ago
Baby Boomers Urged to Get Tested for Hepatitis C Virus
Street Insider, 2 days ago
Hepatitis C challenge to the region
Gulf Times, 1 week ago
Baby boomers need complete testing for hepatitis C virus
Pharmacist.com, 2 weeks ago
|
Prev
| Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
►AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
rediff News App
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Widget
Get Realtime News on your webpage & get your members hooked!
Happening by Location
Click on any location on map to view latest news by location
